Medical Marijuana Prescription Medicine (Medical Cannabis)
CPS II Introduces C-Tech for Medical Cannabis Compliance & Processing
CPS II has developed a Complete Compliance Medical Dispensing system that creates a new standard for dispensing Medical Marijuana Prescription Medicine. CPS II has designed and implemented a new standard for the Medical Marijuana (MMJ) industry.
Since the November 2016 elections there are now 28 States that have legalized and approved Medical Marijuana and have created a new industry to support the medical needs of over 3,000,000 patients that are legally registered in 24 of the 28 states. These Patients are receiving their medicine in a very professional way. The environment that the patients are required to receive their medicine can now be automated with improved controls that meet Medical standards, security, compliance and the legal reporting process.
CPS II has developed an automated, secure technology platform that requires multiple Biometric access with compliance, asset tracking and an encrypted (Block Chain) data reporting process to the departments in each State for Revenue, Agriculture, Health and Marijuana Enforcement. This environment will provide a secure access and set a new standard for the medical marijuana industry. Medical Cannabis Compliance rules BSA/AML, SAR, KYC, PCI & CTR will be monitored and reported by the CPS II process.
The Medical Marijuana Dispensary can chose to implement the BioMetric Medical Marijuana dispensary machine which provides the secure automated dispensing of the Medical Marijuana to each patient or the BioMetric Terminal which allows the patient to select the prescription from a secure terminal. The BioMetric access is a controlled process and will provide a major benefit to the patient, Dispensary and the necessary reporting organizations while creating a positive experience.
The Diseases / Conditions that are known by the medical industry to be addressed by the Medical Marijuana industry cover, AIDS (HIV) & AIDS Wasting, Alzheimer’s Disease, Arthritis, Asthma / Breathing Disorders, Cancer / Nausea / Crohn’s Disease / Gastrointestinal Disorders, Epilepsy / Seizures, Glaucoma, Hepatitis C, Migraines, Multiple Sclerosis / Muscle Spasms, Pain / Analgesia, Psychological Conditions, Tourette Syndrome and the Terminally Ill.
CPS II has identified the Medical Marijuana industry to have a potential revenue of over $6.7 Billion In 2016. Colorado's cannabis industry brought in more than $270 million in the first quarter of 2016 alone. New analysis from the Tax Foundation found nationwide legalization of marijuana could generate up to $28 billion in tax revenues for federal, state, and local governments. That includes $7 billion in federal revenue, $5.5 billion from business taxes, and $1.5 billion from income and payroll taxes. The CPS II technology platform will provide accurate reporting to the required organizations.
The CPS II technology platform will create a standard for the Medical Marijuana industry with new control requirements for medical offices, secure access, digital encrypted patient reporting and accurate revenue, tax, health, agriculture certification along with timely enforcement data on the Dispensaries, Growers and Transporters in the industry.
CPS II has developed a compliance and regulatory process to meet the requirements of the Dodd Frank Act for financial firms. CPS II will be utilizing that technology in support of the Automated medical marijuana platform with a Compliance Navigator which will provide a dashboard for each business unit and State department to monitor and control the environment of the Medical Marijuana industry. This process will provide a secure and well monitored environment for the State to administer the regulations and review the activity in each business unit.
The CPS II technology platform is a cost effective and proven process that can be implemented in a reasonable period of time. The major States that CPS II is engaged in currently are Colorado, California and Nevada.